Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Harte Hanks, Inc. (HHS) vs MaxsMaking Inc. (MAMK)

Harte Hanks, Inc. and MaxsMaking Inc. are both Conglomerates companies. MaxsMaking Inc. is the larger, with a market value of $216.1M against $34.6M — 6.2× the size. Across the 7 metrics below, MaxsMaking Inc. leads on 4 and Harte Hanks, Inc. on 3.

Valuation

Metric HHS MAMK Conglomerates median
P/E n/m — 17.47
P/S 0.22 — 0.88
P/B 2.23 n/m 1.40
Price to free cash flow n/m n/m 12.58
EV/EBITDA n/m n/m 11.36
EV/Sales 0.30 n/m 1.37
Earnings yield (16.49%) — 0.65%
Free cash flow yield (4.23%) 0.00% 0.00%

Profitability

Metric HHS MAMK Conglomerates median
Gross margin 16.86% — 33.55%
Operating margin (3.15%) — 3.36%
Net margin (3.70%) — 0.97%
Free cash flow margin (0.94%) 0.00% (0.94%)
Return on equity (30.41%) — 0.75%
Return on assets (6.24%) — 0.10%
Return on invested capital (23.11%) 0.00% 0.73%

Growth

Metric HHS MAMK Conglomerates median
Revenue growth (TTM) (11.62%) — 8.17%
EPS growth (last fiscal year) 97.35% (100.00%) —
Revenue growth, 5-year CAGR (2.04%) — 6.01%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric HHS MAMK Conglomerates median
Debt to equity 0.20 0.34 0.48
Current ratio 1.30 3.13 1.79
Net debt to EBITDA (1.15) 30.99 1.36

Dividend

Metric HHS MAMK Conglomerates median
Dividend yield — — 2.53%
Payout ratio 0.00 — 0.00

Size

Metric HHS MAMK Conglomerates median
Market cap 34.62m 216.12m 519.65m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack